Hardly. While alli hit the market yesterday, Zimulti, another weight loss drug, suffered a set back. A preliminary FDA panel unanimously rejected this new weight loss pill, citing that there is not enough evidence to support the safety of the drug.
Feed the Fiend!
A fitness blog.
